Hepatitis B Community
Gilead GS9620 Prediction
About This Community:

This forum is an un-mediated, patient-to-patient forum for questions and support regarding Hepatitis B. Topics in this forum include but are not limited to, Causes, Diagnosis, Family and Relationships, Living With Hepatitis B, Research Updates, Treatment, Success Stories, Support, Symptoms.

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

Gilead GS9620 Prediction

I am making a prediction that this drug will be released by Gilead in 2017/2018.

Why?  Gilead loses the patent on Viread in 2017/2018.  Their cash cow will have run its course and they will be more than happy to release this drug to continue to reap the money for HBV treatment.  

There is one thing I remember Dr. Gish telling me that I won't forget.  He said "you know Gilead is working on a drug that will make it so you don't have to take Viread for ever.  It's kind of odd that they'd be working on a drug that will eliminate their Viread income".  

Not really.  If they release it when Viread loses patent, it's a win-win for them!
Tags: GS9620, Gilead, viread, tenofovir
7 Comments Post a Comment
Blank
Avatar_f_tn
"I am making a prediction that this drug will be released by Gilead in 2017/2018. "

Provided that GS9620 shows the expected efficacy on hbvers (and hcvers).
Blank
Avatar_m_tn
They've already done small cohort human trials, and the drug works and is well tolerated.  
Blank
Avatar_f_tn
Really?  They already have a small amount of data on hbvers (human), not just healthy volunteers?  Were they cured?  If so, that would be truly exciting.
Blank
Avatar_m_tn

i do hope myrcludex and replicor are able to fasten this process or imiquimod itself show some effect, this is the only thing to make them move very fast

Blank
Avatar_m_tn
So,
Now, we have three horses running in the course: rep9ac(replicor), mycrludex and GS9620 ..

Good ,, i hope number of horses will increase ..
at least one of them reach to the finalist soooon ..
Blank
Avatar_m_tn
Actually there are 4, if you include the sRNAi from Arrowhead Research.
Blank
Avatar_m_tn
Had appt with Gish - he said there is unreleased data from clinical trials showing GS 9620 has been effective, and non-toxic in escalating doses.  He also said clinical trials are still ongoing and they've relaxed the inclusion criteria, so others may be able to join (veteranB).
Blank
Post a Comment
To
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis B Community Resources
RSS Expert Activity
469720_tn?1388149949
Blank
Abdominal Aortic Aneurysm-treatable... Blank
Oct 04 by Lee Kirksey, MDBlank
242532_tn?1269553979
Blank
The 3 Essentials to Ending Emotiona...
Sep 18 by Roger Gould, M.D.Blank
242532_tn?1269553979
Blank
Control Emotional Eating with this ...
Sep 04 by Roger Gould, M.D.Blank
Top Hepatitis Answerers
Avatar_m_tn
Blank
stef2011
Italy
9624973_tn?1413019730
Blank
melcul
United Kingdom
Avatar_m_tn
Blank
StephenCastlecrag
Australia
Avatar_m_tn
Blank
veteranB
CA
568322_tn?1370169040
Blank
CoWriter
Avatar_m_tn
Blank
luckyman316